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Abstract
Purpose: This study investigates physical performance limitations for sports and daily activities in recently diagnosed
childhood cancer survivors and siblings.
Methods: The Swiss Childhood Cancer Survivor Study sent a questionnaire to all survivors ($16 years) registered in the
Swiss Childhood Cancer Registry, who survived .5 years and were diagnosed 1976–2003 aged,16 years. Siblings received
similar questionnaires. We assessed two types of physical performance limitations: 1) limitations in sports; 2) limitations in
daily activities (using SF-36 physical function score). We compared results between survivors diagnosed before and after
1990 and determined predictors for both types of limitations by multivariable logistic regression.
Results: The sample included 1038 survivors and 534 siblings. Overall, 96 survivors (9.5%) and 7 siblings (1.1%) reported a
limitation in sports (Odds ratio 5.5, 95%CI 2.9-10.4, p,0.001), mainly caused by musculoskeletal and neurological problems.
Findings were even more pronounced for children diagnosed more recently (OR 4.8, CI 2.4–9.6 and 8.3, CI 3.7–18.8 for those
diagnosed ,1990 and $1990, respectively; p = 0.025). Mean physical function score for limitations in daily activities was
49.6 (CI 48.9–50.4) in survivors and 53.1 (CI 52.5–53.7) in siblings (p,0.001). Again, differences tended to be larger in
children diagnosed more recently. Survivors of bone tumors, CNS tumors and retinoblastoma and children treated with
radiotherapy were most strongly affected.
Conclusion: Survivors of childhood cancer, even those diagnosed recently and treated with modern protocols, remain at
high risk for physical performance limitations. Treatment and follow-up care should include tailored interventions to
mitigate these late effects in high-risk patients.
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Introduction
Beyond survival, modern childhood cancer treatment strives to
preserve long-term functionality and health-related quality of life
[1]. While survival rates have reached 80% [2,3], there is
increasing evidence for short- and long-term adverse effects,
including physical performance limitations [4,5]. These can affect
health-related quality of life, reduce educational and occupational
achievements, impede healthy lifestyle and independent living,
and interfere with social development, including interaction with
peers, finding a partner and founding a family [6,7].
There are two broad types of physical activity: a) participation
in sports, and b) participation in activities of daily life [8]. The first
type of activities (sports) is important for social integration with
peers and for preventing or mitigating adverse late effects of
childhood cancer, including cardiovascular disease, obesity,
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osteoporosis, or chronic fatigue [9,10,11]. The second type of
activities (daily activities), is essential for being able to live
independently and enjoy a good quality of life [6].
Only few studies from the US [6,7,12,13,14,15] and one from
the UK [16] investigated physical performance after childhood
cancer. All focused on limitations of daily activities, using questions
from the short form 36 (SF-36) or similar questions from the
Behavioral Risk Factor Surveillance System Questionnaire
(BRFSS) [7,16]. They reported an increased likelihood of physical
performance limitations in survivors compared to siblings or the
general population with odds ratios ranging from 1.8–5.9
[12,14,15]. Survivors of bone tumors, brain tumors, and
Hodgkin’s lymphoma were most affected [12,13,14,15]. Both the
US and UK cohorts studied adult survivors diagnosed and treated
decades ago (US 1970–1986 and UK 1940–1991) [17,18].
We hypothesized that improvements in treatment over time
have decreased the risk of physical performance limitations. Our
study is the first to include recently diagnosed survivors (until
2003), and young survivors still in their adolescence. Moreover,
this is the first study assessing also limitations in sports as well as
the underlying causes. Together with daily activities this covers a
broad spectrum of physical performance.
Using the population-based Swiss Childhood Cancer Survivor
Study (SCCSS), our goal was to compare physical performance
limitations in sports and daily activities of survivors and siblings,
including recently diagnosed survivors. We tested whether these
limitations varied by time period of diagnosis and assessed how
they differed by type of cancer, treatments, and socio-demographic
variables.
Materials and Methods
Ethics statement
Ethics approval was provided through the general cancer
registry permission of the Swiss Childhood Cancer Registry (The
Swiss Federal Commission of Experts for Professional Secrecy in
Medical Research) and a non obstat statement was obtained from
the ethics committee of the canton of Bern, stating that no
additional ethics permission and no additional informed consent
was necessary for the Swiss Childhood Cancer Survivor Study. All
information regarding individuals from the Swiss Childhood
Cancer Survivor Study was made anonymous to investigators
prior to analysis.
The Swiss Childhood Cancer Survivor Study (SCCSS)
The SCCSS is a population-based long-term follow-up study of
all patients registered in the Swiss Childhood Cancer Registry
(SCCR), diagnosed 1976–2003 at an age of 0–15 years, who
survived $5 years [19]. The SCCR includes all children and
adolescents in Switzerland diagnosed with leukemia, lymphoma,
central nervous system (CNS) tumors, malignant solid tumors or
Langerhans cell histiocytosis before age 21 years [20].
In 2007–2010 we traced all addresses of eligible survivors for the
SCCSS and sent them an extensive questionnaire [19]. Non-
responders received another questionnaire and were then
contacted by phone. The questionnaires were similar to those of
the US and UK childhood cancer survivor studies [17,18], but we
added questions on health behaviors and socio-demographic
measures from the Swiss Health Survey 2007 [21] and the Swiss
Census 2000 [22].
Siblings of survivors were recruited as a comparison group. In
the questionnaire, survivors were asked to list their siblings. In
2010–2011 we asked survivors with siblings for consent to contact
them and provide us with their address. Siblings received the same
questionnaire as survivors, without questions relating to cancer
history. Siblings, who did not respond, received the questionnaire
again after 4–6 weeks but were not reminded by phone.
Outcome measures: performance limitations
The questionnaire assessed two different types of performance
limitations:
1) ‘‘Limitations in sports’’ were assessed by asking participants
whether or not they had ‘‘any limitation in sporting activities’’. If
so, they were asked to describe the limitation in detail. Three
pediatricians (CEK, EB, NXvdW) manually coded these answers
into broad categories of medical conditions. When participants
reported more than one problem, the most severe was used for
analysis.
2) ‘‘Limitations in daily activities’’ were defined as low physical
function in the SF-36 [23,24]. The physical function score
aggregates ten questions related to tasks of daily living, such as
carrying groceries, climbing stairs, bending down, walking a
certain distance, dressing or bathing. Raw scores were converted
to T scores (mean = 50, SD = 10) according to age- and sex-
stratified norm data from a public use-file from the German
Federal Survey (N = 6964) [25]. For the logistic regression model
we created a binary variable, using a natural cutoff value below the
5th percentile of the distribution of the sibling population
(score,45). Survivors below this cutoff were defined as ‘‘limited
in daily activities’’. We did sensitivity analyses with a cutoff at 10%
below the siblings’ distribution (score,50), which had been
previously used in other studies [14], and at one standard
deviation below the siblings’ mean (score,47). Predictors from the
regression model did not differ depending on the cutoff.
Explanatory variables
Baseline demographic data and prospectively collected medical
information on diagnosis and treatment of survivors was extracted
from the Swiss Childhood Cancer Registry: gender, age at
diagnosis, cancer diagnosis, cancer treatment, relapse, time since
diagnosis, and age at survey. We used two explanatory variables
assessed by questionnaire: migration background and parental
education.
We used the International Classification of Childhood Cancer –
3rd Edition [26] to classify diagnosis. For the descriptive analysis
treatment modalities were assessed separately. For the regression
models, treatment was hierarchically classified as surgery only,
chemotherapy with or without surgery, radiotherapy with or
without chemotherapy or surgery, and bone marrow transplan-
tation (BMT). Participants were classified as having an immigrant
background if they were not Swiss citizens since birth, not born in
Switzerland, or had at least one parent who was not Swiss citizen.
Parent’s education was divided into three categories: primary
(compulsory schooling only); secondary (including vocational
training, teachers, technical and commercial schools etc.); and
tertiary (including university and university of applied sciences)
[22,27].
Statistical Analysis
Using Stata version 11.0, we analyzed data for all survivors and
siblings aged $16 years at time of survey. Results from siblings
were age and sex standardized for comparison.
First, we determined the proportion of survivors and siblings
reporting a limitation for sports and the reasons for these
limitations. Survivors and siblings were compared by logistic
Activity Limitations after Childhood Cancer
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regression adjusted for age and sex. In a sensitivity analysis the
regression model was also adjusted for family clustering [28].
Second, we described limitations in daily activities using the SF-
36 physical function score and its single items. We compared mean
scores of survivors and siblings using linear regression adjusted for
age and sex. Again, we adjusted for family clustering in a
sensitivity analysis.
Third, we tested whether results from step one and two differed
between survivors diagnosed 1976–89 and 1990–2003, respec-
tively. In a sensitivity analysis we did step one and two for
survivors diagnosed in the last 5 years of our cohort only (1998–
2003).
Finally, we used univariable and multivariable logistic regres-
sion models to identify predictors of both types of performance
limitations in survivors, and likelihood ratio tests to calculate
global p-values.
Results
Study population
We traced addresses of 1445 of 1552 eligible survivors
(Figure S1). Of those, 1121 (78%) returned a questionnaire,
1038 (72%) the full-length questionnaire, and 83 (6%) an
abbreviated version without questions on performance limitations.
Participants (n = 1038), in comparison to non-participants
(n = 514) (Table 1), were more often female (48% vs. 37%;
p =,0.001), aged 20–30 years (52% vs. 43%; p = 0.011), and
treated with BMT (8% vs. 3%; p,0.001). They did not differ by
type of cancer, age at diagnosis, time since diagnosis or treatment.
Most survivors had suffered from leukemia (37%), lymphoma
(19%) or a CNS tumor (13%), 67% had been treated with surgery,
84% with chemotherapy and 38% with radiotherapy of whom 167
(42.5%) received cranial irradiation. Of the 80 participants who
had bone marrow transplantation (BMT), 48 (60%) were treated
with autologous BMT and 30 (37.5%) with allogeneic BMT. Mean
age at diagnosis was 7.7 years (SD 4.7) and mean time elapsed
since diagnosis 18.2 years (SD 6.9). We received consent to contact
1293 siblings. Of those, 534 (41%) returned a questionnaire.
Limitations in sports
Overall, 96 (9.5%; 95% Confidence Interval (CI) 7.8–11.4)
survivors reported a limitation in sports (Table 2). Most
limitations were caused by musculoskeletal problems (n = 43,
4.2%), followed by neurological problems (n = 27, 2.7%), and pain
and fatigue syndromes (n = 7, 0.7%). Among those with limita-
tions, 14 survivors (1.3% of 1038) reported a severe handicap such
as dependence on a wheel chair. Twenty survivors (1.9%) reported
more than one limitation. Type of limitation differed by type of
diagnosis (Table S1). For example most survivors of CNS tumors
suffered from neurological problems and survivors of bone tumors
or lymphoma from musculoskeletal problems.
Among siblings, only 7 (1.1%; CI 0.6–2.1) reported a limitation
in sports (Table 2). None was severely handicapped or reported
more than one limitation. The odds ratio (OR) for limitations in
sports, comparing survivors to siblings, was 5.5 (CI 2.9–10.4;
p,0.001). This remained similar after adjusting for family
clustering (OR = 5.5; CI 3.0–10.0; p,0.001).
Limitations on daily activities (physical function (PF)
score SF-36)
For every item of the PF score survivors reported more
limitations than siblings (Table 2), with the biggest discrepancies
seen for walking-related activities of daily life and bathing or
dressing. Survivors reached a mean PF score of 49.6 (CI 48.9–
50.4) compared to a mean of 53.1 (CI 52.5–53.7) in siblings.
Adjusting for age and sex, the mean difference was 23.3 (CI
24.5–2.1; p,0.001). Results remained similar (mean differ-
ence =23.3; CI 24.2–2.4; p,0.001) when adjusting for family
clustering.
Survivors diagnosed before and after 1990
We compared results for survivors diagnosed from 1976-89 with
those diagnosed 1990–2003 (Tables S2 and S3). Prevalence of
limitations and differences to siblings remained similar in survivors
diagnosed more recently, or tended even to increase. In the first
period, 8.8% of survivors and 1.6% of siblings reported a
limitation (OR 4.8; CI 2.4–9.6), in the more recent period
10.1% of survivors and 0.6% of siblings (OR 8.3; CI 3.7–18.8;
p = 0.025 for effect modification between the two periods).
Mean PF score for daily activities was 50.4 in survivors and 53.5
in siblings of the first period (mean difference 23.1; CI 24.2–1.9),
and 48.9 and 52.7, respectively in the second period (mean
difference 23.6; CI 25.0–2.1; p = 0.356 for effect modification
between the two periods).
When looking only at survivors diagnosed in the last 5 years of
our cohort (1998–2003) results were even more pronounced.
Among survivors, 12.2% (CI 7.6%–19.0%) reported to suffer from
limitations in sporting activities compared to 0.4% of siblings (CI
0.1%–2.4%; OR for age- and sex-adjusted difference between
survivors and siblings = 20.8, CI 6.1–71.2, p,0.001). Survivors
diagnosed in the last 5 years had a mean physical function score of
46.4 (CI 43.5–49.4) compared to 52.4 in siblings (CI 51.1–53.7;
Coeff. for age- and sex-adjusted mean difference =26.0, CI
28.0–4.0, p,0.001; data available from the author).
Predictors of limitations in sports (survivors only)
Figure 1A shows how the proportion of survivors reporting a
limitation in sports varied by type of cancer (p,0.001). Survivors
of bone tumors were most affected (34% reporting a limitation),
followed by survivors of CNS tumors (23%), retinoblastoma (19%),
and soft tissue sarcoma (13%).
In the unadjusted regression model (Table S4) factors associ-
ated with limitations in sports were: having had a CNS tumor (OR
7.1; CI 3.7–13.8), retinoblastoma (OR 5.6; CI 1.7–18.7), bone
tumor (OR 12.3; CI 5.4–28.2), or soft tissue sarcoma (OR 3.5; CI
1.4–8.9) and having received radiotherapy (OR 2.1; CI 1.3–3.3).
Survivors aged $40 years tended to be more limited (p = 0.072).
Results from the adjusted regression model (Table 3) were
comparable, the strongest predictors remaining type of cancer and
treatment.
Predictors of limitations in daily activities (survivors only)
The mean physical function (PF) score also differed by type of
cancer (Figure 1B), with lowest scores in survivors of bone tumors
(mean PF score 40.7), followed by survivors of CNS tumors (43.6)
and retinoblastoma (45.8). In the unadjusted model (Table S4)
factors associated with limitations on daily activities were: low
parental education (p = 0.024), having received radiotherapy or
bone marrow transplantation (p,0.001) and having suffered from
a bone tumor or CNS tumor (p,0.001). Results of the adjusted
regression model were similar, showing even stronger associations
for type of cancer and treatments (Table 3).
Discussion
This nationwide survey including survivors of all types of
childhood cancers diagnosed until 2003 found that survivors were
five times more likely than siblings to suffer from limitations in
Activity Limitations after Childhood Cancer
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Table 1. Characteristics of the study population, comparing participants, non-participants and siblings of the current analysis.
Survivor participants
(n =1038)
Sibling participantsa
(n =534)
Survivor non-participantsb
(n =514)
n %c n %c n %c p-valued
Gender ,0.001
Male 545 52.5 282 52.8 322 62.7
Female 493 47.5 252 47.3 192 37.4
Age (years) 0.011
,20 234 22.5 110 20.6 138 26.9
–29.9 536 51.6 293 54.9 219 42.6
30–39.9 228 22.0 111 20.8 133 25.9
$40 40 3.9 20 3.8 24 4.7
Migration background
None (Swiss) 795 76.6 454 85.1 n.a.e
Germany, Austria, France 39 3.8 16 3.0
Italy, Spain 87 8.4 33 6.1
Other countries 117 11.3 31 5.9
Education of parents
Primary education 88 8.5 37 7.0 n.a.e
Secondary education 726 69.9 342 64.1
Tertiary education 160 15.4 85 15.9
Unknown 64 6.2 70 13.0
Age at diagnosis (years) 0.136
,5 372 35.8 n.a.f 202 39.3
5–9.9 286 27.6 150 29.2
$10 380 36.6 162 31.5
Time since diagnosis (years) 0.866
,10 134 12.9 n.a.f 63 12.3
10–19.9 483 46.5 231 44.9
20–29.9 351 33.8 184 35.8
$30 70 6.7 36 7.0
Diagnosis (ICCC-3) 0.609
I Leukemia 383 36.9 n.a.f 169 32.9
II Lymphoma 195 18.8 107 20.8
III CNS tumor 132 12.7 67 13.0
IV Neuroblastoma 45 4.3 20 3.9
V Retinoblastoma 21 2.0 15 2.9
VI Renal tumor 70 6.7 29 5.6
VII Hepatic tumor 5 0.5 2 0.4
VIII Bone tumor 42 4.1 16 3.1
IX Soft tissue sarcoma 56 5.4 30 5.8
X Germ cell tumor 30 2.9 18 3.5
XI & XII Other tumorg 12 1.2 7 1.4
Langerhans Cell Histiocytosis 47 4.5 34 6.6
Therapyh
Surgery 698 67.2 n.a.f 357 69.5 0.380
Chemotherapy 871 83.9 419 81.5 0.236
Radiotherapy 393 37.9 214 41.6 0.152
Bone Marrow Transplantation 80 7.7 14 2.7 ,0.001
Activity Limitations after Childhood Cancer
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Table 1. Cont.
Survivor participants
(n =1038)
Sibling participantsa
(n =534)
Survivor non-participantsb
(n =514)
n %c n %c n %c p-valued
Relapse 0.041
yes 107 10.3 n.a.f 71 13.8
No 931 89.7 443 86.2
NOTE: Percentages are based upon available data for each variable.
Abbreviations: CNS, Central Nervous System; ICCC-3, International Classification of Childhood Cancer – Third Edition; n, number; n.a., not applicable.
aAge- and sex-standardized numbers and percentages are given for siblings.
bNon participants include: 107 without current address, 239 who did not respond, 85 who refused to participate, and 83 who answered an abridged questionnaire
(Supplementary Figure S1).
cColumn percentages are given.
dP-value calculated from chi-square statistics comparing survivor participants and survivor non-participants.
eInformation derived from questionnaire survey is not available for non-responders.
fInformation on former cancer disease is not applicable for siblings.
gOther malignant epithelial neoplasms, malignant melanomas and other or unspecified malignant neoplasms.
hEach person can have had several treatments.
doi:10.1371/journal.pone.0047944.t001
Table 2. Description of limitations in sporting activities and daily activities in survivors and siblings.
Survivors Siblingsa
Limitation in sporting activities
Medical conditions N % 95% CI N % 95% CI ORb 95% CI p-valuec
Musculoskeletal problems 43 4.2 3.2–5.7 3 0.5 0.2–1.2
Neurological problems 27 2.7 1.8–3.9 2 0.3 0.1–1.1
Pain and fatigue syndromes 7 0.7 0.3–1.4 0 0 -
Weight and endurance problems 5 0.5 0.2–1.2 0 0 -
Cardio-pulmonary problems 3 0.3 0.1–0.9 1 0.2 0.02–1.1
Visual impairment 3 0.3 0.1–0.9 0 0 -
Psychological problems 2 0.2 0.1–0.8 0 0 -
Problem unknown 6 0.6 0.3–1.3 1 0.2 0.02–1.2
Total proportion 96 9.5 7.8–11.4 7 1.1 0.6–2.1 5.5b 2.9–10.4 ,0.001
Limitations in daily activities
Items of physical function score N % 95% CI N % 95% CI Diff.d 95% CI p-valuec
Vigorous activities 336 32.6e 29.8–35.6 91 17.0e 14.0–20.6
Moderate activities 91 8.9e 7.3–10.8 14 2.7e 1.6–4.6
Carrying groceries 82 8.0e 6.5–9.8 19 3.6e 2.3–5.7
Climbing several flights of stairs 108 10.5e 8.8–12.6 21 3.9e 2.5-6.0
Climbing one flight of stairs 34 3.3e 2.4–4.6 4 0.7e 0.3–1.9
Bending down 124 12.1e 10.2–14.2 29 5.5e 3.7–8.2
Walking more than 1 kilometer 98 9.5e 7.9–11.5 12 2.3e 1.2–4.3
Walking several 100 meters 57 5.5e 4.3–7.1 5 0.9e 0.4–2.1
Walking 100 meters 38 3.7e 2.7–5.0 4 0.8e 0.4–1.9
Bathing or dressing 29 2.8e 2.0–4.0 4 0.7e 0.3–1.9
Physical function score
(mean)
49.6f 48.9–50.4 53.1f 52.5–53.7 23.3d 24.5–2.1 ,0.001
Abbreviations: CI, Confidence Interval; Diff., Difference; N, Number; SF-36, Short Form 36; OR, Odds Ratio.
aAge- and sex-standardized numbers and percentages are given for siblings based on the marginal distribution in survivors.
bOR comparing survivors and siblings in a logistic model adjusting for age and sex.
cP-values calculated from regression models adjusting for age and sex.
dCoefficient comparing mean score in survivors and siblings from linear regression adjusting for age and sex.
eProportion who indicated to be limited either a lot or a little in single items if the SF-36 physical function score.
fMean of T-standardized physical function score of the SF-36 (23).
doi:10.1371/journal.pone.0047944.t002
Activity Limitations after Childhood Cancer
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Figure 1. Limitations in sports (proportions) and daily activities (mean SF-36 physical function score) by type of diagnosis.
aDiagnosis is classified according to the International Classification of Childhood Cancer – third edition [26]. Abbreviations: CNS, Central Nervous
System. Figure 1A shows the proportion of survivors reporting a limitation for sporting activities within each diagnostic group. The dotted line
Activity Limitations after Childhood Cancer
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sports and that they had significantly lower physical function
scores for activities of daily life. Limitations differed strongly
between diagnostic groups, with poorest results for survivors of
bone tumors, CNS tumors and retinoblastoma. Importantly, we
found no evidence that limitations had decreased in survivors
diagnosed recently (1990–2003) and treated according to modern
protocols.
Strengths and limitations
This study has several strengths. It is a representative
population-based national cohort study of all Swiss childhood
cancer survivors (response rate 78%) as well as their siblings. In
contrast to studies from the US, we included all types of childhood
cancers, particularly retinoblastoma, a strongly affected group.
Our study included survivors from a large age range starting with
adolescents, and covered a broad spectrum of activity limitations
by assessing both limitations in sports and daily activities. With our
open formatted question on the reasons for limitations in sports,
we could collect additional information on the underlying causes
of limitations in childhood cancer survivors. Finally, a major
strength is the wide time period of diagnosis (1976–2003), allowing
to evaluate limitations in children diagnosed recently.
The study has also limitations. One is the self-reported
assessment of performance limitations, which our study shares
with others from the US and UK [17,18]. We assessed limitations
in sporting activities with an open formatted question to identify
individual and subjective reasons that keep survivors from being
active. Though this might differ from survivors’ objective
possibilities of physical performance, subjectively experienced
limitation is usually more important for practicing sporting
activities. Not participating in sporting activities can affect the
survivors’ health and social contacts [6,7]. Another limitation is
the comparatively low response rate of siblings, making it unclear
if the sample is fully representative for the whole sibling
population.
Comparison with other studies
We are not aware of any other studies reporting on limitations
in sports of childhood cancer survivors. However, limitations in
daily activities have been described by the US childhood cancer
survivor study in different contexts [6,7,12,13,14,15]. As all results
relate to children diagnosed between 1970–1986 they can be
compared to the older half of our cohort. One study used the SF-
36 and reported mean PF scores of 51.3 in 7147 adult survivors
and 55.0 in 388 siblings [15]. This is similar to our findings for
children diagnosed before 1990, where mean scores were 50.4 and
53.5 for survivors and siblings, respectively. Comparable to our
findings are also differences by type of cancer, with survivors of
bone tumors, CNS tumors, Hodgkin’s Lymphoma and soft tissue
sarcomas scoring lowest. Retinoblastoma patients had not been
included in the US study [15].
Another study used the Behavioral Risk Factor Surveillance
System Questionnaire (BRFSS) in a sample of 11481 adolescent
and adult survivors and 3839 siblings [14], and found more
performance limitations in survivors than siblings (OR 1.8, CI 1.7–
2.0). Using a different cut-off, Hudson and colleagues found more
activity limitations (OR = 2.7) in 9535 adult survivors compared to
2961 siblings [12]. In line with our findings, both studies reported
the highest risks in survivors of bone and brain tumors [12,14].
Interpretation of the results
Our study confirmed that survivors of childhood cancer have a
high risk of physical performance limitations, both in sports and
activities of daily life. On physical function score of daily activities
survivors scored on average 3.3 points below Siblings. Although
this mean difference might not be clinically relevant, it suggests
that specific subgroups of survivors may have clinically relevant
limitations in daily living. For example survivors of bone tumors
on average score 12.4 points below the siblings’ mean (Figure 1B)
and survivors of CNS tumor 9.5 points; both are of clinical
relevance.
As a novel finding, we identified underlying disorders, showing
that musculoskeletal and neurological problems were most
common, followed by pain and fatigue syndromes, weight and
endurance problems and cardio-pulmonary symptoms. Limita-
tions were in line with the underlying type of cancer (Table S1),
such that most survivors of brain tumors reported neurological
problems, and survivors of bone tumors reported musculoskeletal
problems.
Predictors were similar for limitations in sport and daily
activities, underlining the robustness of our results. As expected
from previous studies, three diagnostic groups were most strongly
affected: survivors of bone tumors, often treated by amputations or
other major limb surgery [7,13], survivors of CNS tumors, with
problems of coordination, balance, muscle strength, paralysis,
vision or hearing [29], and retinoblastoma patients, suffering from
blindness or severe visual impairments [30].
We had hypothesized that improved therapy, such as limb-
sparing surgery [31], minimally invasive retinoblastoma therapy
[32], and reduction in cranial irradiation might have reduced the
risk of physical activity limitations in more recently diagnosed
patients. This was not the case in our population. Survivors
diagnosed after 1990 had a similar risk for performance limitations
as those diagnosed earlier and performed at least as badly
compared to age- and sex-adjusted siblings. If anything, they fared
worse rather than better. The observed difference between periods
of diagnosis may not be clinically relevant. However, our results
with their 95% confidence intervals provide strong evidence
against an improvement in more recent treatment periods. One
possible explanation for a lack of improvement in more recently
diagnosed survivors might be that improved therapies result in less
severe limitations, but not necessarily less common limitations
[30,33]. Or patients who would not have survived in earlier
decades, can nowadays be cured but with a high risk for
performance limitations due to an increased burden of therapy.
For example the introduction of hematopoietic growth factors or
the widespread use of high-dose chemotherapy with autologous
stem-cell rescue [34,35,36,37]. Finally, more recently diagnosed
survivors might have had less time to cope with their impairments
and rate their limitations subjectively different.
Implication for practice
Survival rates in childhood cancer have improved markedly [2],
and it is time to improve quality of survivorship [1]. Quality of life
indicates the proportion in the sibling controls. Figure 1B shows limitations for daily activities (mean scores of the physical function score from the SF-
36) stratified by type of diagnosis. Lower scores indicate increased limitations for daily tasks such as walking fast, carry heavy things, move a table,
carry grocery bags, climbing stairs, bending down, walking a certain distance, bathing and clothing. The dotted line indicates the mean score of the
sibling controls.
doi:10.1371/journal.pone.0047944.g001
Activity Limitations after Childhood Cancer
PLOS ONE | www.plosone.org 7 October 2012 | Volume 7 | Issue 10 | e47944
includes independent living and ability to participate in physical
activities and social life roles [6,38]. It is therefore important to
preserve functional capacity and reduce the burden of perfor-
mance limitations in survivors. This can be done by choosing the
best therapy, offering physical activity interventions, reducing
obesity, developing coping strategies, and enhancing psycho-social
well-being [9,39,40].
Table 3. Predictors of limitations in sports and daily activities (physical function score ,45) from two multivariable regression
models in survivors.
Limited in sports Limited in daily activities
%a OR 95% CI pc %b OR 95% CI pc
Gender 0.367 0.158
Male 8.5 1 13.2 1
Female 10.5 1.23 0.78 1.95 16.7 1.31 0.90 1.90
Current age (years) 0.061 0.496
#20 10.3 1.13 0.62 2.07 19.0 1.45 0.90 2.32
20–29.9 9.7 1 13.5 1
30–39.9 6.5 0.63 0.32 1.22 14.6 1.05 0.64 1.72
$40 20.5 2.70 1.02 7.16 15.4 0.97 0.36 2.63
Parents education 0.035 0.008
Primary education 4.6 0.40 0.13 1.18 20.5 1.89 1.03 3.49
Secondary education 9.8 1 13.7 1
Tertiary education 8.9 0.98 0.51 1.87 12.6 1.01 0.58 1.76
Unknown 15.9 2.97 1.19 7.39 26.6 2.80 1.46 5.38
Age at diagnosis (years) 0.964 0.387
,5 8.1 1 14.6 1
5–9.9 9.7 1.04 0.55 1.97 14.3 0.72 0.43 1.19
$10 10.7 1.10 0.56 2.14 15.6 0.92 0.54 1.56
Diagnosis (ICCC3 main groups) ,0.001 ,0.001
I Leukemia 4.0 1 9.2 1
II Lymphoma 5.7 1.16 0.49 2.74 8.2 0.89 0.45 1.75
III CNS tumor 23.2 9.40 4.26 20.74 30.5 5.76 3.08 10.80
IV Neuroblastoma 11.1 3.77 1.23 11.55 15.6 2.42 0.95 6.17
V Retinoblastoma 19.1 8.55 2.26 32.33 19.1 2.88 0.82 10.10
VI & VII Renal & hepatic tumord 6.8 1.65 0.57 4.80 16.0 2.19 1.04 4.63
VIII Bone tumor 34.2 13.59 5.55 33.28 45.2 10.87 5.04 23.45
IX Soft tissue sarcoma 12.7 2.87 1.07 7.70 16.1 1.76 0.77 4.04
X Germ cell tumor 6.9 2.11 0.44 10.12 10.0 1.15 0.31 4.19
XI & XII Other tumore 18.2 5.72 1.03 31.76 16.7 1.86 0.34 10.02
Langerhans Cell Histiocytosis 4.4 1.62 0.35 7.52 15.2 2.91 1.15 7.35
Treatment ,0.001 ,0.001
Surgery only 8.2 0.35 0.13 0.90 13.2 0.50 0.23 1.07
Chemotherapyf 7.0 1 10.3 1
Radiotherapyg 13.6 1.61 0.90 2.88 20.6 2.08 1.31 3.32
Bone marrow transplantation 8.1 0.85 0.22 3.28 25.6 2.98 1.24 7.14
Relapse 0.880 0.326
No 9.3 1 14.2 1
Yes 11.3 1.06 0.52 2.13 20.6 1.32 0.76 2.29
Abbreviations: CI, Confidence Interval; CNS, Central Nervous System; ICCC-3, International Classification of Childhood Cancer Third Edition; OR, Odds Ratio.
aProportion reporting a limitation in sports in each stratum. Column percentages are given.
bProportion reporting a limitation in daily activities in each stratum. Column percentages are given.
cGlobal p-values calculated with a likelihood ratio test.
dHepatic and renal tumors have been merged for this analysis.
eOther malignant epithelial neoplasm, malignant melanoma and other or unspecified malignant neoplasm.
fChemotherapy may include surgery.
gRadiotherapy may include surgery and/or chemotherapy.
doi:10.1371/journal.pone.0047944.t003
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Our results show that main risk factors for performance
limitations were type of cancer and subsequent treatment. Thus,
at-risk groups are clear, and interventions could start early after or
even during therapy. In principle, performance limitations can be
avoided or mitigated by primary or secondary prevention
strategies.
Primary prevention would be through adaptations of initial
therapy. In fact, during the past decades much effort has been put
into developing minimally invasive surgical techniques and reducing
radiotherapy. Treatment of retinoblastoma with eye-preserving
techniques and reduced chemotherapy should lead to better
functional outcomes [32,41]. The same was hoped for limb-sparing
surgery for bone tumors. However, first studies did not confirm
functionally better results for limb-sparing surgery compared to
amputations [33]. In our population, these changes in therapy, which
have also been implemented in Switzerland, have not translated to a
sizeable reduction in performance limitations. This suggests that
there is still room for improvement of minimally invasive therapy
techniques and ongoing research is justified and needed.
Secondary prevention is another option for reducing perfor-
mance limitations and improving quality of survivorship. Many of
the common limitations described by survivors in this study, e.g.
musculoskeletal and neurological problems, fatigue syndromes,
weight, endurance and cardio-pulmonary problems have been
shown to respond to interventions during or after treatment [42].
Several studies suggest that physical activity interventions begin-
ning during treatment and continuing during follow-up can reduce
performance limitations, improve quality of life, reduce obesity,
pain and fatigue and increase independent living status and
psychosocial well-being [9,10,40,42,43,44,45,46]. To encourage
lifelong physical activity, exercise programs should be individually
tailored, home-based, implemented into daily living, and connect-
ed to fun and social contacts [8,46,47]. During follow-up
consultations physicians but also nursing specialists or physiother-
apists could encourage engagement in physical activity and
develop personal strategies to include specially needed exercises
into daily living. They could for example hand out leaflets with
coordinative exercises to be done 10 minutes every day for
survivors with neurological problems. Or they could help survivors
to find the optimal type of activity and reduce barriers for being
active (help for participation in sports club, fitness center, sports
class for handicapped, individual sports etc.).
Conclusion
Despite modern treatments and protocols, survivors of child-
hood cancer, particularly after bone tumors, brain tumors and
retinoblastoma, are at great risk of suffering from performance
limitations in sports and activities of daily living. Early, life-long
and individually tailored interventions aimed at reducing perfor-
mance limitations should be implemented in the care of high-risk
patients.
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